Author:
Tegueni Kokou,Gbeasor-Komlanvi Fifonsi Adjidossi,Adama Oumarou I. Wone,Sadio Arnold Junior,Amenyah-Ehlan Amivi Phyllis,Dagnra Claver Anoumou,Ekouevi Didier Koumavi
Abstract
Summary
Background
In 2015, Togo introduced the “test-and-treat” strategy for the prevention of mother-to-child transmission (PMTCT) of HIV. Pediatric HIV infection remains a public health problem in Togo, with a mother-to-child transmission (MTCT) rate of 3.6% in 2020. This study aimed to estimate cases of HIV seroconversion during pregnancy and to identify pregnant women at high risk of transmitting HIV to their children in Lomé, Togo.
Methods
A descriptive cross-sectional study was carried out from 18 March to 22 May 2022 among women who had given birth in five maternity units providing PMTCT services in Lomé. Umbilical cord blood samples were taken from the maternal side by midwives after delivery. HIV serology was performed in the laboratory using the Alere™ HIV Combo SET and First Response HIV 1–2. Card Test version 2.0. A sample was considered positive if both tests were positive. The HIV-1 viral load in HIV-1-positive samples was measured using Cobas/Roche 4800 equipment. Information on the women was extracted from maternal antenatal records and antenatal consultation registers.
Results
A total of 3148 umbilical cord blood samples (median maternal age: 28 years (interquartile range [24–32]) were collected. Among them, 99.3% (3145/3148) had presented for at least one antenatal clinic visit before giving birth, and 78.7% (2456/3122) had presented for at least four visits. One hundred and twenty-one (121) cord samples were HIV-1 positive, representing a seroprevalence of 3.8% (95% CI = [3.2–4.6]). Among them, 67.8% (82/121) were known HIV-positive before the current pregnancy, 29.7 (36/121) were diagnosed as HIV-positive at the antenatal visits and 2.5% (3/121) were diagnosed as HIV-positive in the delivery room. Of the HIV-positive women, 85.9% (104/121) were on ARV treatment before delivery. The viral load was < 1000 copies/ml in 97.5% (118/121) cases.
Conclusion
This study explored the virologic and epidemiological aspects of HIV among pregnant women in Togo. The results show significant viral suppression at delivery in women ART. Surveillance based on umbilical cord blood specimen screening is an interesting approach for monitoring the effectiveness of PMTCT programmes.
Funder
Centre Africain de Recherche en Epidémiologie et en Santé Publique (CARESP), Togo
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS Data – 2021. Geneva: UNAIDS; 2021. p. 468.
2. Chi BH, Mbori-Ngacha D, Essajee S, Mofenson LM, Tsiouris F, Mahy M, et al. Accelerating progress towards the elimination of mother-to-child transmission of HIV: a narrative review. J Int AIDS Soc. 2020;23(8):e25571. https://doi.org/10.1002/jia2.25571.
3. The United Nations International Children’s Emergency Fund (UNICEF). A child was infected with HIV every two minutes in 2020 [Internet]. 2021 [Cited, february 7th, 2023]. Available from: https://www.unicef.org/press-releases/child-was-infected-hiv-every-two-minutes-2020-unicef.
4. Rasmussen DN, Vieira N, Hønge BL, da Silva Té D, Jespersen S, Bjerregaard-Andersen M, et al. HIV-1 and HIV-2 prevalence, risk factors and birth outcomes among pregnant women in Bissau, Guinea-Bissau: a retrospective cross-sectional hospital study. Sci Rep. 2020;10(1):12174. https://doi.org/10.1038/s41598-020-68806-5.
5. Turan JM, Onono M, Steinfeld RL, Shade SB, Owuor K, Washington S et al. Implementation and Operational Research: Effects of Antenatal Care and HIV Treatment Integration on Elements of the PMTCT Cascade: Results From the SHAIP Cluster-Randomized Controlled Trial in Kenya. J Acquir Immune Defic Syndr. 1999. 2015;69:e172-181.